Thorac Cardiovasc Surg 2017; 65(03): 165
DOI: 10.1055/s-0037-1601426
Editorial
Georg Thieme Verlag KG Stuttgart · New York

The Aortic Valve in < 140 Characters

Markus K. Heinemann
1   Department of Cardiac, Thoracic and Vascular Surgery, University Hospital Mainz, Mainz, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
06 April 2017 (online)

To keep up with modern times The Editing House has decided to circulate Tweetitorials from now on. Here are some experimental samples. (NOTE: content purely fictitious; for technical trial run purposes only!)

editorinchief01 (7:17 am): Unbelievable! TAVI to be extended to intermediate risk! All to survive! This is GREAT news!

editorinchief01 (8:44 am): This is SICK! Sources now say there is still a risk associated with TAVI. If this turns out to be true we'll see them in court!

editorinchief01 (8:48 am): TAVI a good option for valve-in-valve solutions in degenerated bioprostheses! Two publications - Now we are talking! A NEW HIGH!

editorinchief01 (1:51 pm ): ThCVS top-ranked cardiac surgery journal because of highest impact TAVI articles!

editorinchief01 (2:47 pm ): JThCVS, Ann Thor Surg, EJCTS also have a great impact. We love you guys!

editorinchief01 (6:19 pm): Aortic valves can still be replaced through various thoracotomies.

editorinchief01 (6:22 pm): Mechanical valve prostheses are still available and implanted!! CARBON LIVES! Could be a great DEAL for the coal-miners!

editorinchief01 (11:06 pm): Infective endocarditis is BAD NEWS! Brush your teeth! I am vigorously brushing right now. Good night!